According to HealthEquity's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.51. At the end of 2025 the company had a P/S ratio of 7.98.
Year | P/S ratio | Change |
---|---|---|
2025 | 7.98 | 21.71% |
2024 | 6.55 | 4.69% |
2023 | 6.26 | -20.99% |
2022 | 7.92 | 6.29% |
2021 | 7.45 | 40.62% |
2020 | 5.30 | -46.42% |
2019 | 9.89 | -53.02% |
2018 | 21.1 | 49.28% |
2017 | 14.1 | 19.87% |
2016 | 11.8 | -27.2% |
2015 | 16.2 | 16% |
2014 | 13.9 |